Department of Gynecology and Obstetrics, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Breast. 2012 Aug;21(4):435-9. doi: 10.1016/j.breast.2012.01.007. Epub 2012 Feb 20.
Recent epidemiological studies demonstrated that alcohol dehydrogenase 1C (ADH1C) alleles that result in acetaldehyde accumulation in the cells can enhance a drinker's risk of developing alcohol related cancer in a variety of tissues. The published data on the association between ADH1C alleles and breast cancer occurrence in Caucasians have led to in contradictory results. This meta-analysis of literatures was performed to derive a more precise estimation of the relationship.
A total of 12 studies were identified to the meta-analysis, including 6159 cases and 5732 controls from Caucasians. The pooled odds ratio (OR) with 95% confidence interval (CI) for breast cancer risk associated with ADH1C genotype was estimated.
Overall, no significantly elevated breast cancer risk was found in all genetic models when all studies were pooled into the meta-analysis (ADH1C(1-2) vs. ADH1C(2-2): OR 1.07, 95% CI 0.97-1.19; ADH1C(1-1) vs. ADH1C(2-2): OR 1.16, 95% CI 0.94-1.43; dominant model: OR 1.07, 95% CI 0.97-1.18; recessive model: OR 1.06, 95% CI 0.93-1.20). There was no evidence for the association between ADH1C genotype and breast cancer risk in subgroup analyses based on design of experiment and menopausal status. And for the additive model, individuals carrying the ADH1C*(1) allele were not significantly associated with increased risk to breast cancer (OR 1.01, 95% CI 0.97-1.06).
This meta-analysis suggests that ADH1C polymorphism may not be associated with breast cancer development in Caucasians. And larger scale primary studies are required to further evaluate the interaction of ADH1C polymorphism and breast cancer risk in specific populations.
最近的流行病学研究表明,导致细胞中乙醛积累的乙醛脱氢酶 1C(ADH1C)等位基因可以增加饮酒者在多种组织中发生与酒精相关的癌症的风险。已发表的关于 ADH1C 等位基因与高加索人群乳腺癌发生之间关联的数据导致了相互矛盾的结果。进行这项文献荟萃分析是为了更准确地评估这种关系。
对文献进行荟萃分析,共纳入 12 项研究,包括来自高加索人群的 6159 例病例和 5732 例对照。估计 ADH1C 基因型与乳腺癌风险相关的合并优势比(OR)及其 95%置信区间(CI)。
总体而言,当将所有研究纳入荟萃分析时,所有遗传模型均未发现乳腺癌风险显著升高(ADH1C(1-2)与 ADH1C(2-2):OR 1.07,95%CI 0.97-1.19;ADH1C(1-1)与 ADH1C(2-2):OR 1.16,95%CI 0.94-1.43;显性模型:OR 1.07,95%CI 0.97-1.18;隐性模型:OR 1.06,95%CI 0.93-1.20)。基于实验设计和绝经状态的亚组分析,没有发现 ADH1C 基因型与乳腺癌风险之间存在关联。对于加性模型,携带 ADH1C*(1)等位基因的个体与乳腺癌风险增加无关(OR 1.01,95%CI 0.97-1.06)。
本荟萃分析表明,ADH1C 多态性与高加索人群乳腺癌的发生无关。需要更大规模的初步研究来进一步评估 ADH1C 多态性与特定人群乳腺癌风险的相互作用。